Page last updated: 2024-08-24

triazoles and gsk 1363089

triazoles has been researched along with gsk 1363089 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abudayyeh, O; Barzily-Rokni, M; Cooper, ZA; Fisher, DE; Flaherty, KT; Frederick, DT; Garraway, LA; Hahn, WC; Haq, R; Johannessen, CM; Kim, JW; Konieczkowski, DJ; Mesirov, JP; Piris, A; Straussman, R; Tamayo, P; Wargo, JA	1

Other Studies

1 other study(ies) available for triazoles and gsk 1363089

Article	Year
A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors. Cancer discovery, 2014, Volume: 4, Issue:7 Topics: Anilides; Benzimidazoles; Benzocycloheptenes; Cell Line, Tumor; Cells, Cultured; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Humans; Indoles; MAP Kinase Signaling System; Melanocytes; Melanoma; Microphthalmia-Associated Transcription Factor; NF-kappa B p50 Subunit; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-met; Pyridines; Quinolines; Sulfonamides; Triazoles	2014

Article

Year

A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors.

Cancer discovery, 2014, Volume: 4, Issue:7

Topics: Anilides; Benzimidazoles; Benzocycloheptenes; Cell Line, Tumor; Cells, Cultured; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Humans; Indoles; MAP Kinase Signaling System; Melanocytes; Melanoma; Microphthalmia-Associated Transcription Factor; NF-kappa B p50 Subunit; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-met; Pyridines; Quinolines; Sulfonamides; Triazoles

2014